Transplantation in remission improves the disease-free survival of patients with advanced myelodysplastic syndromes treated with myeloablative T cell-depleted stem cell transplants from HLA-identical siblings
about
Palifermin is efficacious in recipients of TBI-based but not chemotherapy-based allogeneic hematopoietic stem cell transplants.NCI First International Workshop on the Biology, Prevention, and Treatment of Relapse after Allogeneic Hematopoietic Stem Cell Transplantation: report from the Committee on the Epidemiology and Natural History of Relapse following Allogeneic Cell TrThe identification and characterization of zebrafish hematopoietic stem cells.Impact of the revised International Prognostic Scoring System, cytogenetics and monosomal karyotype on outcome after allogeneic stem cell transplantation for myelodysplastic syndromes and secondary acute myeloid leukemia evolving from myelodysplastiReduced late mortality risk contributes to similar survival after double-unit cord blood transplantation compared with related and unrelated donor hematopoietic stem cell transplantation.Comparison of outcomes at two institutions of patients with ALL receiving ex vivo T-cell-depleted or unmodified allografts.Current status of allogeneic hematopoietic cell transplantation for MDS.Recombinant human interleukin-7 (CYT107) promotes T-cell recovery after allogeneic stem cell transplantationCD34-Selected Hematopoietic Stem Cell Transplants Conditioned with Myeloablative Regimens and Antithymocyte Globulin for Advanced Myelodysplastic Syndrome: Limited Graft-versus-Host Disease without Increased RelapseMonosomal karyotype at the time of diagnosis or transplantation predicts outcomes of allogeneic hematopoietic cell transplantation in myelodysplastic syndrome.Novel strategies for adoptive therapy following HLA disparate transplantsT cell-depleted stem cell transplantation for adults with high-risk acute lymphoblastic leukemia: long-term survival for patients in first complete remission with a decreased risk of graft-versus-host disease.Ex vivo T-cell depletion in allogeneic hematopoietic stem cell transplant: past, present and future.Early recovery of T-cell function predicts improved survival after T-cell depleted allogeneic transplant.A Chemotherapy-Only Regimen of Busulfan, Melphalan, and Fludarabine, and Rabbit Antithymocyte Globulin Followed by Allogeneic T-Cell Depleted Hematopoietic Stem Cell Transplantations for the Treatment of Myeloid Malignancies.Hematopoietic Cell Transplantation Comorbidity Index Predicts Outcomes in Patients with Acute Myeloid Leukemia and Myelodysplastic Syndromes Receiving CD34+ Selected Grafts for Allogeneic Hematopoietic Cell Transplantation.Low incidence of GvHD with T-cell depleted allografts facilitates further treatments for post-transplantation relapse in AML and MDS.A novel clofarabine bridge strategy facilitates allogeneic transplantation in patients with relapsed/refractory leukemia and high-risk myelodysplastic syndromes.Monosomal karyotype predicts poor survival after allogeneic stem cell transplantation in chromosome 7 abnormal myelodysplastic syndrome and secondary acute myeloid leukemia.Allogeneic stem cell transplantation for myelodysplastic syndromes in children: a report from the Spanish Working Party for Blood and Marrow Transplantation in Children (GETMON).Durable graft-versus-leukaemia effects without donor lymphocyte infusions - results of a phase II study of sequential T-replete allogeneic transplantation for high-risk acute myeloid leukaemia and myelodysplasia.Long-term prognosis for 1-year relapse-free survivors of CD34+ cell-selected allogeneic hematopoietic stem cell transplantation: a landmark analysis.Disease burden and conditioning regimens in ASCT1221, a randomized phase II trial in children with juvenile myelomonocytic leukemia: A Children's Oncology Group study.
P2860
Q33745865-BE2A0284-CC90-4F0E-9220-2536E1AECDDDQ34044024-B6BB45F3-7A2C-46AE-AAC9-07A1D0599D67Q35112228-6D63415F-9D6E-402A-9BF7-313C676A6794Q35146316-E41C9DCD-4486-45AB-95AB-40DF4AC3C572Q35167190-4DDB90F4-EE32-4DB4-AE55-1545A9F9D1B0Q35243578-A8D17615-8175-4AA8-B048-0A68EF0AD7EBQ36063049-156FF557-0435-4225-B8B0-9660EC0C6DFEQ36462428-78C9725B-C5CC-4A8D-9911-422EE9E256E7Q36608689-4C9B11CA-E056-4FD9-AAF7-0CC34E020C58Q36683757-A738285F-AD47-4521-B242-E15422C23B6CQ37504394-AE75DB94-F312-432F-A994-AAD80F01AE13Q37659142-3A310BC5-8E20-4296-841E-F3AF8F63E05EQ38742867-F68583C9-5169-4661-9C98-6E2B6CA5414DQ39028818-3FF02ECF-A2EB-4FA4-91F3-B7508927F82BQ40121414-9D88AF8D-08C9-45A8-B3DF-20564AFD36A6Q40508324-50436057-3C4F-4336-B964-7DD50D4A7C41Q40881086-335F82A8-BB9B-4211-B1BE-82E51FC29688Q43085409-24BA703E-08DA-43AB-951D-50E69BCA9788Q43451303-1C1FCA49-19CF-4ACF-92D0-DC50FF2E5657Q45938989-AED9C977-3AE9-4D54-9935-4E91A4B84F52Q47598339-061C1A92-5651-49D5-9029-778D6DB92F11Q49391428-331F7EF3-DA38-4AF1-A456-AFEE1F7C8BE1Q52661221-D3513316-7E6E-43C4-A3BC-F3F2A278E861
P2860
Transplantation in remission improves the disease-free survival of patients with advanced myelodysplastic syndromes treated with myeloablative T cell-depleted stem cell transplants from HLA-identical siblings
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
Transplantation in remission i ...... ts from HLA-identical siblings
@ast
Transplantation in remission i ...... ts from HLA-identical siblings
@en
type
label
Transplantation in remission i ...... ts from HLA-identical siblings
@ast
Transplantation in remission i ...... ts from HLA-identical siblings
@en
prefLabel
Transplantation in remission i ...... ts from HLA-identical siblings
@ast
Transplantation in remission i ...... ts from HLA-identical siblings
@en
P2093
P2860
P1476
Transplantation in remission i ...... ts from HLA-identical siblings
@en
P2093
Ann A Jabubowski
Esperanza B Papadopoulos
Farid Boulad
Glenn Heller
Hugo Castro-Malaspina
James W Young
Katharine Hsu
Marcel van den Brink
Michelle Chiu
Miguel A Perales
P2860
P304
P356
10.1016/J.BBMT.2008.02.006
P577
2008-04-01T00:00:00Z